244 related articles for article (PubMed ID: 9702464)
1. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus.
Blann AD; Lip GY
Diabet Med; 1998 Aug; 15(8):634-42. PubMed ID: 9702464
[TBL] [Abstract][Full Text] [Related]
2. Soluble markers of endothelial cell function.
Blann A; Seigneur M
Clin Hemorheol Microcirc; 1997; 17(1):3-11. PubMed ID: 9181753
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
[TBL] [Abstract][Full Text] [Related]
4. Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis.
John S; Jacobi J; Delles C; Schlaich MP; Alter O; Schmieder RE
Clin Sci (Lond); 2000 May; 98(5):521-9. PubMed ID: 10781382
[TBL] [Abstract][Full Text] [Related]
5. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.
Thorand B; Baumert J; Chambless L; Meisinger C; Kolb H; Döring A; Löwel H; Koenig W;
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):398-405. PubMed ID: 16322530
[TBL] [Abstract][Full Text] [Related]
6. Von Willebrand factor in diabetic angiopathy.
Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
[TBL] [Abstract][Full Text] [Related]
7. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.
Glowinska B; Urban M; Peczynska J; Florys B
Metabolism; 2005 Aug; 54(8):1020-6. PubMed ID: 16092051
[TBL] [Abstract][Full Text] [Related]
8. Persistent arterial stiffness and endothelial dysfunction following successful pancreas-kidney transplantation in Type 1 diabetes.
Stadler M; Theuer E; Anderwald C; Hanusch-Enserer U; Auinger M; Bieglmayer C; Quehenberger P; Bischof M; Kästenbauer T; Wolzt M; Wagner O; Prager R
Diabet Med; 2009 Oct; 26(10):1010-8. PubMed ID: 19900233
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
10. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
Blann AD; Lip GY; Beevers DG; McCollum CN
Thromb Haemost; 1997 Jun; 77(6):1077-80. PubMed ID: 9241735
[TBL] [Abstract][Full Text] [Related]
11. Putative role of adhesion molecules in metabolic disorders.
Wagner OF; Jilma B
Horm Metab Res; 1997 Dec; 29(12):627-30. PubMed ID: 9497900
[TBL] [Abstract][Full Text] [Related]
12. Effect of the antioxidants selenium and beta-carotene on HIV-related endothelium dysfunction.
Constans J; Seigneur M; Blann AD; Renard M; Resplandy F; Amiral J; Guérin V; Boisseau MR; Conri C
Thromb Haemost; 1998 Dec; 80(6):1015-7. PubMed ID: 9869176
[TBL] [Abstract][Full Text] [Related]
13. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
Caballero AE; Saouaf R; Lim SC; Hamdy O; Abou-Elenin K; O'Connor C; Logerfo FW; Horton ES; Veves A
Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in diabetes mellitus.
Cosentino F; Lüscher TF
J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S54-61. PubMed ID: 9883749
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects.
Knudsen ST; Jeppesen P; Frederiksen CA; Andersen NH; Bek T; Ingerslev J; Mogensen CE; Poulsen PL
Diabet Med; 2007 Aug; 24(8):911-5. PubMed ID: 17559428
[TBL] [Abstract][Full Text] [Related]
16. [Selected adhesion molecules: sICAM-1 and sVCAM-1 as markers of endothelial dysfunction in diabetic children and adolescence].
Głowińska B; Urban M; Peczyńska J; Szczepańska-Kostro J
Pol Merkur Lekarski; 2003 Mar; 14(81):205-9. PubMed ID: 12914095
[TBL] [Abstract][Full Text] [Related]
17. Assessment of platelets and the endothelium in patients presenting with acute coronary syndromes--is there a future?
Derhaschnig U; Jilma B
Thromb Haemost; 2009 Dec; 102(6):1144-8. PubMed ID: 19967144
[No Abstract] [Full Text] [Related]
18. Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes Adrenomedullin and vascular risk factors in Type 1 DM.
García-Unzueta MT; Berrazueta JR; Pesquera C; Obaya S; Fernández MD; Sedano C; Amado JA
J Diabetes Complications; 2005; 19(3):147-54. PubMed ID: 15866060
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
Mastej K; Adamiec R
Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
[TBL] [Abstract][Full Text] [Related]
20. Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis.
Bloom BJ; Nelson SM; Eisenberg D; Alario AJ
J Rheumatol; 2005 Feb; 32(2):366-72. PubMed ID: 15693101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
